Anti-biofilm Wound Dressing Market Report 2023: R&D Consistency Drives Sector GrowthPosted by Ganesh Shinde on February 17th, 2023 The net worth of the market share of the Anti-Biofilm Wound Dressingis predicted to reach from US$ 782.60 million in 2023 to over US$ 1939.45 million by 2033, recording a CAGR of 9.5% between 2023 and 2033. Incidence rates for chronic and acute wounds are expected to increase which is, driving demand for anti-biofilm wound dressings. Besides antimicrobial resistance and unhealthy sedentary lifestyles, tobacco and alcohol consumption contribute to the rising non-communicable disease burden. This is because chronic diseases such as diabetes, cancer, and other autoimmune diseases become more prevalent. There are also several other factors contributing to the market's growth, including the development of healthcare infrastructure across developing countries, and technological advancements in wound management. The efforts made by healthcare providers and key players to make wound care more popular. “Telehealth has played a key role in the strong recovery of the wound care market. Various healthcare providers have developed telehealth platforms to effectively manage patients with chronic and acute wounds.”says a lead analyst at Future Market Insights. Key Takeaways from Market Study
Competitive Landscape: Several prominent companies dominate this market, including ConvaTec, Smith & Nephew PLC, Urgo Medical, Coloplast, and 3M. Anti-biofilm wound dressing has developed significantly in the industry through partnerships, acquisitions, and research and development. These strategies have resulted in major developments. Get More Insights@ https://www.futuremarketinsights.com/reports/anti-biofilm-wound-dressing-market Anti-biofilm Wound Dressing Market Segmentation by Category By Mode of Mechanism:
By Wound Type:
By End User:
Like it? Share it!More by this author |